Compounds > 4,5,6,7-tetrabromo-2-azabenzimidazole
Page last updated: 2024-10-21

4,5,6,7-tetrabromo-2-azabenzimidazole and Ovarian Neoplasms

4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Ovarian Neoplasms in 1 studies

4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, CS1
Jang, ER1
Kim, YJ1
Myung, SC1
Kim, W1

Other Studies

1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Ovarian Neoplasms

ArticleYear
Casein kinase 2 inhibition differentially modulates apoptotic effect of trichostatin A against epithelial ovarian carcinoma cell lines.
    Molecular and cellular biochemistry, 2010, Volume: 338, Issue:1-2

    Topics: Animals; Apigenin; Apoptosis; Casein Kinase II; Cell Line, Tumor; Cell Nucleus; DNA Fragmentation; E

2010